{"id":"NCT03503513","sponsor":"University of Michigan","briefTitle":"Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury","officialTitle":"The Effect of Gentamicin Intravesical Installations on Decreasing Urinary Tract Infections in Patients With Neurogenic Bladder After Spinal Cord Injury: A Clinical Trial","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2018-08-24","primaryCompletion":"2023-09-08","completion":"2023-09-30","firstPosted":"2018-04-19","resultsPosted":"2024-06-25","lastUpdate":"2024-06-25"},"enrollment":23,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Urinary Tract Infections","Spinal Cord Injuries","Spinal Cord Diseases","Neurogenic Bladder"],"interventions":[{"type":"DRUG","name":"Gentamicin Sulfate","otherNames":["Gent Instillations"]}],"arms":[{"label":"Gentamicin sulfate","type":"EXPERIMENTAL"}],"summary":"A non-randomized study evaluating the efficacy of intravesical gentamicin on the occurrence rate of urinary tract infections and bladder complications in patients after spinal cord injury (SCI), and to assess its effectiveness in promoting overall quality of life (QOL), community living, and participation.","primaryOutcome":{"measure":"Number of Urinary Tract Infections (UTI) Over Time","timeFrame":"6 months prior to treatment and 6 months during treatment","effectByArm":[{"arm":"Gentamicin Sulfate","deltaMin":0.53,"sd":null}],"pValues":[{"comp":"OG000","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":12},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":19},"commonTop":["Urinary Tract Infection","COVID-19","bladder spasms","flu-like symptoms","Clinically significant labs"]}}